Tampa, Florida
Colorectal cancer clinical trials in Tampa, FL
41 colorectal cancer studies are recruiting participants at sites in Tampa as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Tampa at a glance
- 41 studies are recruiting at a site in Tampa.
- By phase: Phase 1 (16), Phase 1/2 (6), Phase 2 (5), Phase 2/3 (2), Phase 3 (2), No phase (4), Observational (6). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (30), university, hospital or other (11).
- Most recent update to one of these records: November 16, 2026.
Studies recruiting in Tampa
Basic details from each study's public record (the 30 most recently updated of 41). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Study site
- H. Lee Moffitt Cancer Center and Research Institute
- Registry record
- NCT06324357 · updated
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 to 99
- All sexes
- Sponsor
- Erasca, Inc.
- Study site
- Moffitt Cancer Center
- Registry record
- NCT06983743 · updated
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab or Bevacizumab Plus Chemotherapy in RAS and BRAF Wild Type, Recurrent, Unresectable or Metastatic Colorectal Cancer (LiGeR-CRC2)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Genmab
- Study site
- Moffitt Cancer Center
- Registry record
- NCT07775287 · updated
Shield Post-Approval Study Protocol
- Observational
- Ages 45 to 81
- All sexes
- Sponsor
- Guardant Health, Inc.
- Study sites
- NMC Research · Top Research of West Florida, LLC
- Registry record
- NCT06880055 · updated
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kestrel Therapeutics, Inc.
- Study site
- Moffitt Cancer Center
- Registry record
- NCT07458347 · updated
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study site
- Moffitt Cancer Center
- Registry record
- NCT07659795 · updated
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Moffitt Cancer Center
- Registry record
- NCT04929223 · updated
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Oncolytics Biotech
- Study site
- Moffitt Cancer Center
- Registry record
- NCT07446322 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- Moffitt Cancer Center · Moffitt Cancer Center - McKinley Campus · Moffitt Cancer Center-International Plaza
- Registry record
- NCT05174169 · updated
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Observational
- Ages 40 to 75
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Saint Joseph's Hospital/Children's Hospital-Tampa
- Registry record
- NCT05334069 · updated
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Wake Forest University Health Sciences
- Study site
- Saint Joseph's Hospital/Children's Hospital-Tampa
- Registry record
- NCT06418204 · updated
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Moffitt
- Registry record
- NCT07114601 · updated
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Moffitt
- Registry record
- NCT07213791 · updated
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- A2 Biotherapeutics Inc.
- Study site
- Moffitt Cancer Center
- Registry record
- NCT04981119 · updated
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Alterome Therapeutics, Inc.
- Registry record
- NCT06835569 · updated
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Moffitt Cancer Center
- Registry record
- NCT07221357 · updated
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Delcath Systems Inc.
- Study site
- Moffitt Cancer Center
- Registry record
- NCT06607458 · updated
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- Moffitt Cancer Center /ID# 279325
- Registry record
- NCT07525206 · updated
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- Moffitt Cancer Center /ID# 274372
- Registry record
- NCT07023289 · updated
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Bicara Therapeutics
- Study site
- H. Lee Moffitt Cancer Center and Research Institute, Inc
- Registry record
- NCT04429542 · updated
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Dispatch Biotherapeutics
- Study site
- Moffitt Cancer Center
- Registry record
- NCT07544589 · updated
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- No phase
- Ages 65 to 82
- All sexes
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Study site
- James A. Haley Veterans Hospital
- Registry record
- NCT05612347 · updated
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Exelixis
- Study site
- Exelixis Clinical Site #8
- Registry record
- NCT05176483 · updated
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
- Study site
- Moffitt Cancer Center
- Registry record
- NCT06625775 · updated
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- ALX Oncology Inc.
- Study site
- ALX Center 7
- Registry record
- NCT07085091 · updated
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Moffitt Cancer Center and Research Institute
- Registry record
- NCT06128551 · updated
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Moffitt Cancer Center
- Registry record
- NCT06445062 · updated
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Blueprint Medicines Corporation
- Study site
- Moffitt Cancer Center
- Registry record
- NCT07629960 · updated
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Aktis Oncology, Inc.
- Study site
- Moffitt Cancer Center
- Registry record
- NCT07020117 · updated
Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
- No phase
- Ages 45 to 75
- All sexes
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Study site
- Moffitt Cancer Center
- Registry record
- NCT06745895 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Tampa, FL on ClinicalTrials.gov.
Ask about studies near Tampa
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Florida
All Florida locations
132 studies recruiting across 62 cities.
Jacksonville
29 studies recruiting.
Orlando
23 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections